Investors in Cambridge, United Kingdom
Updated 16 Nov 2026
Venture funds
5 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Amadeus Capital Partners Amadeus Capital Partners invests across seed to later stages in the technology sector, with recent investments including Nuclera and Nu Quantum. Cambridge, United Kingdom |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 29% | 5 |
| 2 | Cambridge Innovation Capital Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica. Cambridge, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 36% | 3 |
| 3 | Martlet Capital Martlet Capital provides early-stage patient capital to deep tech and life science startups, including Dogtooth, Infinitopes and Nu Quantum. Cambridge, United Kingdom |
Hardware, Biotech | Seed, Early stage venture | 14% | 3 |
| 4 | University of Cambridge Enterprise Cambridge, United Kingdom |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 37% | 3 |
| 5 | SyndicateRoom SyndicateRoom builds diversified portfolios of 50+ startups through co-investing with UK angel investors, with recent investments in Noggin HQ and Incard. Cambridge, United Kingdom |
Artificial intelligence, Fintech | Seed, Early stage venture | 9% | 2 |
Table 1. Investors in Cambridge, United Kingdom: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Amadeus Capital Partners | Venture capital firm | Cambridge, United Kingdom | •••@amadeuscapital.com | +44 33••• |
| SyndicateRoom | Micro VC fund | Cambridge, United Kingdom | •••@syndicateroom.com | 01223 ••• |
| University of Cambridge Enterprise | University program | Cambridge, United Kingdom | •••@enterprise.cam.ac.uk | +44 (0••• |
| Cambridge Innovation Capital | Venture capital firm | Cambridge, United Kingdom | •••@cic.vc | +44 (0••• |
| Martlet Capital | Venture capital firm | Cambridge, United Kingdom | •••@martletcap.com | 01223 ••• |
| Cambridge Capital Group | Angel group | Cambridge, United Kingdom | •••@cambridgecapital.com | +44 (0••• |
| Fund Twenty8 | Micro VC fund | Cambridge, United Kingdom | •••@syndicateroom.com | +44 12••• |
| Deeptech Labs | Startup accelerator | Cambridge, United Kingdom | •••@dtl.vc |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 23 of the 59 investors in Cambridge, United Kingdom have a published email address, 20 a phone number and 28 a website.
- Amadeus Capital Partners has the most recorded investments, 293, 86 of them as lead investor.
- 8 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Amadeus Capital Partners is an investor in 5 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 140 portfolio companies (72%).
- Seed is the most common investment stage, recorded for 48 of them (81%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Investors in Cambridge, United Kingdom
28 of 59, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Amadeus Capital Partners | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Hardware | iPronics, Tenzo, Refute | 5 | 293 | 86 | 64 | •••@amadeuscapital.com | +44 33••• | In the CSV |
| 2 | SyndicateRoom | Micro VC fund, Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Fintech | Noggin HQ, Incard | 2 | 135 | 12 | 11 | •••@syndicateroom.com | 01223 ••• | In the CSV |
| 3 | University of Cambridge Enterprise | University program, Venture capital firm | Cambridge, United Kingdom | Health care, Artificial intelligence | T-Therapeutics, Gigaton, Seprify | 3 | 104 | 38 | 7 | •••@enterprise.cam.ac.uk | +44 (0••• | In the CSV |
| 4 | Cambridge Innovation Capital | Venture capital firm | Cambridge, United Kingdom | Hardware, Artificial intelligence | T-Therapeutics, Microbiotica, Salience Labs | 3 | 97 | 35 | 12 | •••@cic.vc | +44 (0••• | In the CSV |
| 5 | Carbon13 | Startup accelerator | Cambridge, United Kingdom | Artificial intelligence, Biotech | Ki 13, Fermtech, Cocoon | 4 | 56 | 33 | 0 | In the CSV | ||
| 6 | Martlet Capital | Venture capital firm | Cambridge, United Kingdom | Hardware, Biotech | Dogtooth, Infinitopes, Nu Quantum | 3 | 51 | 7 | 5 | •••@martletcap.com | 01223 ••• | In the CSV |
| 7 | Cambridge Capital Group | Angel group | Cambridge, United Kingdom | Fintech, Hardware | Arachnys, Augmentra, 10to8 | 45 | 4 | 12 | •••@cambridgecapital.com | +44 (0••• | In the CSV | |
| 8 | Fund Twenty8 | Micro VC fund | Cambridge, United Kingdom | Biotech, Health care | Metrion Biosciences, 2mee, inflo.Ai | 35 | 1 | 1 | •••@syndicateroom.com | +44 12••• | In the CSV | |
| 9 | Meltwind Advisory | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Biotech | CoSyne Therapeutics | 30 | 4 | 0 | 01223 ••• | In the CSV | ||
| 10 | Deeptech Labs | Startup accelerator | Cambridge, United Kingdom | Artificial intelligence, Hardware | Salience Labs, Xapien | 2 | 27 | 2 | 1 | •••@dtl.vc | In the CSV | |
| 11 | Cambridge Future Tech | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Hardware | Literal Labs, Neuro XR, Mission Decisions | 15 | 11 | 0 | •••@camfuturetech.com | In the CSV | ||
| 12 | Accelerate@Babraham | Startup accelerator, Startup incubator | Cambridge, United Kingdom | Biotech, Health care | VisusNano | 14 | 13 | 0 | •••@babraham.co.uk | (+44) ••• | In the CSV | |
| 13 | Qi3 Ventures | Startup accelerator | Cambridge, United Kingdom | 10 | 3 | 2 | •••@qi3.co.uk | +44 (0••• | In the CSV | |||
| 14 | Invoke Capital | Private equity firm, Venture capital firm | Cambridge, United Kingdom | 9 | 6 | 3 | •••@invokecapital.com | +44 (0••• | In the CSV | |||
| 15 | Acacia Capital Partners | Venture capital firm | Cambridge, United Kingdom | Hardware | Skinkers | 9 | 2 | 3 | •••@acaciacp.com | +44-(0••• | In the CSV | |
| 16 | Start Codon | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Biotech | coding.bio | 8 | 2 | 0 | •••@startcodon.co | +44 78••• | In the CSV | |
| 17 | ETCapital | Venture capital firm | Cambridge, United Kingdom | Hardware | Cyan Technology Ltd | 7 | 1 | 1 | •••@etcapital.com | +44122••• | In the CSV | |
| 18 | NW Brown Ventures | Venture capital firm | Cambridge, United Kingdom | Software | Spikes Cavell & Co, Short Fuze | 5 | 0 | 2 | •••@nwbrown.co.uk | +44 (0••• | In the CSV | |
| 19 | Cambridge Agritech | Syndicate | Cambridge, United Kingdom | 4 | 1 | 0 | •••@camagritech.com | +44 79••• | ||||
| 20 | CMS Ventures | Venture capital firm | Cambridge, United Kingdom | 4 | 1 | 0 | •••@cmsventures.com | In the CSV | ||||
| 21 | CREATE Partners | Venture capital firm | Cambridge, United Kingdom | Software | Short Fuze | 4 | 1 | 1 | •••@createpartners.com | 44 (0)••• | ||
| 22 | James Sore | Angel investor | Cambridge, United Kingdom | 3 | 0 | 0 | In the CSV | |||||
| 23 | Neil Davidson | Angel investor | Cambridge, United Kingdom | Hardware, Cybersecurity | CryptoSeal | 3 | 0 | 3 | In the CSV | |||
| 24 | David Ford | Angel investor | Cambridge, United Kingdom | 2 | 1 | 0 | In the CSV | |||||
| 25 | The Valkin Group | Family office, Private equity firm | Cambridge, United Kingdom | Fintech | OceanX AI | 1 | 1 | 0 | •••@valkintrading.com | In the CSV | ||
| 26 | Brightstar Partners | Venture capital firm | Cambridge, United Kingdom | 1 | 0 | 0 | •••@brightstar-partners.com | In the CSV | ||||
| 27 | Downing Enterprise | Startup accelerator, Entrepreneurship program | Cambridge, United Kingdom | 1 | 0 | 0 | •••@downingenterprise.co.uk | 01223 ••• | In the CSV | |||
| 28 | The Discovery Fund, Cambridge University | Micro VC fund, University program | Cambridge, United Kingdom | 1 | 0 | 0 | •••@cusu.cam.ac.uk | +44 (0••• |
Table 2. Investors in Cambridge, United Kingdom: the first 28 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 59.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Amadeus Capital Partners | Cambridge, United Kingdom | 5 | 36 | iPronics, Tenzo, Refute |
| 2 | Carbon13 | Cambridge, United Kingdom | 4 | 15 | Ki 13, Fermtech, Cocoon |
| 3 | Cambridge Innovation Capital | Cambridge, United Kingdom | 3 | 11 | T-Therapeutics, Microbiotica, Salience Labs |
| 4 | University of Cambridge Enterprise | Cambridge, United Kingdom | 3 | 10 | T-Therapeutics, Gigaton, Seprify |
| 5 | Martlet Capital | Cambridge, United Kingdom | 3 | 8 | Dogtooth, Infinitopes, Nu Quantum |
| 6 | Deeptech Labs | Cambridge, United Kingdom | 2 | 6 | Salience Labs, Xapien |
| 7 | SyndicateRoom | Cambridge, United Kingdom | 2 | 27 | Noggin HQ, Incard |
| 8 | Hermann Hauser | Cambridge, United Kingdom | 1 | 7 | Quantrol Ox |
Table 3. Investors in Cambridge, United Kingdom: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | Cambridge Innovation Capital, University of Cambridge Enterprise | 51 to 100 | 2022 |
| Quantrol Ox | QuantrolOx builds machine learning control software that tunes and stabilizes qubits for quantum technologies. | Artificial intelligence | Espoo, Finland | Series A | $13.5M | 2026-10-22 | $21.5M | Hermann Hauser | 11 to 50 | 2021 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge, United Kingdom | Series C | $47.9M | 2026-10-16 | $130.7M | Cambridge Innovation Capital | 11 to 50 | 2016 |
| Salience Labs | Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning. | Artificial intelligence | Oxford, United Kingdom | Series B | $125.0M | 2026-10-14 | $166.5M | Cambridge Innovation Capital, Deeptech Labs | 51 to 100 | 2021 |
| Xapien | Xapien provides AI-powered due diligence and risk intelligence on people, organizations, and business relationships. | Artificial intelligence | London, United Kingdom | Series B | $55.9M | 2026-09-10 | $73.8M | Deeptech Labs | 51 to 100 | 2018 |
| iPronics | iPronics develops programmable optical networking systems for AI data centers and high-performance computing. | Artificial intelligence | Valencia, Spain | Series B | $125.0M | 2026-09-02 | $164.2M | Amadeus Capital Partners | 101 to 250 | 2019 |
| Ki 13 | Ki 13 is a deep-tech venture that develops waste-to-hydrogen technology. | Energy | London, United Kingdom | Seed | $5.0M | 2026-09-02 | $6.1M | Carbon13 | 1 to 10 | 2022 |
| Noggin HQ | Noggin HQ provides credit reference services to assess and report on individuals' creditworthiness. | Fintech | Newcastle Upon Tyne, United Kingdom | Seed | $3.1M | 2026-08-18 | $4.1M | SyndicateRoom | 1 to 10 | 2021 |
| Dogtooth | Dogtooth sells intelligent robots that pick soft fruit. | Hardware | Royston, United Kingdom | Series B | $18.7M | 2026-07-08 | $34.5M | Martlet Capital | 11 to 50 | 2014 |
| Gigaton | Gigaton develops artificial intelligence to help energy-intensive industries reduce their carbon emissions. | Artificial intelligence | London, United Kingdom | Series A | $26.0M | 2026-06-02 | $32.5M | University of Cambridge Enterprise | 11 to 50 | 2020 |
Table 4. Investors in Cambridge, United Kingdom: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 101 | 72% |
| Artificial intelligence | 41 | 29% |
| Hardware | 33 | 24% |
| Health care | 21 | 15% |
| Fintech | 21 | 15% |
| Biotech | 16 | 11% |
| Cybersecurity | 11 | 8% |
| Commerce | 11 | 8% |
| Energy | 1 | 1% |
| Education | 1 | 1% |
Table 5. Investors in Cambridge, United Kingdom: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Seed investors | 48 | 81% |
| Early stage investors | 23 | 39% |
| Late stage investors | 5 | 8% |
| Private equity investors | 4 | 7% |
| Venture investors | 3 | 5% |
| Grant makers | 2 | 3% |
Table 6. Investors in Cambridge, United Kingdom by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 4 | 14% |
| 2010s | 11 | 39% |
| 2000s | 7 | 25% |
| 1990s | 3 | 11% |
| 1980s | 1 | 4% |
| 1970s | 1 | 4% |
Table 7. Investors in Cambridge, United Kingdom by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its headquarters is in Cambridge, United Kingdom. On 16 November 2026 that is 59 investors.
- 23 rows carry an email address and 20 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 28 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 59 rows: 31 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many investors in Cambridge, United Kingdom are on the list?
- 59, in the file dated 16 November 2026. 8 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 23 of the 59 carry an email address in the download and 20 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 59 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 59 rows, 23 firm email addresses and 20 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 21 of the 23 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.